Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Firefly Neuroscience (AIFF) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Firefly Neuroscience (AIFF) over the last 13 years, with Q3 2025 value amounting to 0.05.

  • Firefly Neuroscience's Asset Utilization Ratio rose 18757.26% to 0.05 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05, marking a year-over-year increase of 18757.26%. This contributed to the annual value of 0.09 for FY2023, which is 8666.88% down from last year.
  • Per Firefly Neuroscience's latest filing, its Asset Utilization Ratio stood at 0.05 for Q3 2025, which was up 18757.26% from 0.02 recorded in Q2 2025.
  • Firefly Neuroscience's 5-year Asset Utilization Ratio high stood at 3.59 for Q1 2021, and its period low was 0.0 during Q1 2025.
  • For the 5-year period, Firefly Neuroscience's Asset Utilization Ratio averaged around 0.96, with its median value being 0.78 (2022).
  • Examining YoY changes over the last 5 years, Firefly Neuroscience's Asset Utilization Ratio showed a top increase of 18757.26% in 2025 and a maximum decrease of 9943.68% in 2025.
  • Firefly Neuroscience's Asset Utilization Ratio (Quarter) stood at 0.92 in 2021, then dropped by 2.24% to 0.9 in 2022, then rose by 19.31% to 1.07 in 2023, then plummeted by 98.4% to 0.02 in 2024, then surged by 187.57% to 0.05 in 2025.
  • Its Asset Utilization Ratio stands at 0.05 for Q3 2025, versus 0.02 for Q2 2025 and 0.0 for Q1 2025.